Pfizer Inc. (PFE)
undefined
undefined%
At close: undefined
26.54
-0.21%
After-hours Dec 26, 2024, 07:58 PM EST

Pfizer Inc. Revenue Breakdown

Quarter Sep 29, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Oct 1, 2023Jul 2, 2023Apr 2, 2023Dec 31, 2022Oct 2, 2022Jul 3, 2022Apr 3, 2022Dec 31, 2021Oct 3, 2021Jul 4, 2021Apr 4, 2021Dec 31, 2020Sep 27, 2020Jun 28, 2020Mar 29, 2020Dec 31, 2019Sep 29, 2019Jun 30, 2019Mar 31, 2019Jun 28, 2015Mar 29, 2015Dec 31, 2014Sep 28, 2014Jun 29, 2014Mar 30, 2014Dec 31, 2013Sep 29, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jul 1, 2012Apr 1, 2012Dec 31, 2011Oct 2, 2011Jul 3, 2011
Biopharma Segment Revenue 17.39B 2.07B 2.17B 1.91B 1.65B 1.97B 2.06B 2.22B 1.69B 2.32B 2.31B 1.93B 2.07B 1.88B 1.77B 0 22.35B 21.60B 22.04B 0 22.79B 22.86B 22.30B 10.88B 9.95B 12.08B 11.42B 11.73B 10.48B 12.48B 11.74B 12.11B 11.55B 12.89B 12.12B 13.14B 13.06B 28.36B 14.75B 14.64B
Biopharma Segment Revenue Growth +741.41% -4.83% +13.72% +16.11% -16.37% -4.51% -7.08% +31.26% -27.10% +0.13% +19.65% -6.48% +10.00% +6.21% n/a -100.00% +3.47% -1.99% n/a -100.00% -0.31% +2.49% +104.99% +9.40% -17.69% +5.81% -2.63% +11.91% -16.03% +6.29% -3.04% +4.88% -10.45% +6.40% -7.78% +0.57% -53.93% +92.31% +0.73% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Developed Europe Revenue 11.65B 21.98B 18.34B 7.79B 8.70B 9.12B 8.51B 9.31B 9.71B 11.72B 11.74B 13.38B 16.30B 16.66B
Developed Europe Revenue Growth -47.00% +19.88% +135.44% -10.49% -4.55% +7.15% -8.58% -4.20% -17.11% -0.17% -12.23% -17.93% -2.21% n/a
Developed Rest Of World Revenue 7.76B 15.78B 12.51B 4.04B 6.46B 6.55B 6.61B 6.73B 6.30B 7.31B 8.35B 10.55B 11.09B 10.09B
Developed Rest Of World Revenue Growth -50.81% +26.16% +209.86% -37.57% -1.31% -0.92% -1.74% +6.84% -13.89% -12.37% -20.92% -4.84% +9.91% n/a
Emerging Markets Revenue 12.00B 20.10B 20.70B 8.37B 12.73B 12.65B 11.40B 10.42B 11.14B 11.50B 11.22B 11.97B 13.10B 12.01B
Emerging Markets Revenue Growth -40.31% -2.92% +147.26% -34.25% +0.65% +10.98% +9.40% -6.43% -3.16% +2.44% -6.23% -8.65% +9.14% n/a
United States Revenue 27.09B 42.47B 29.75B 21.71B 23.85B 25.33B 26.03B 26.37B 21.70B 19.07B 20.27B 23.09B n/a n/a
United States Revenue Growth -36.22% +42.79% +37.00% -8.97% -5.83% -2.68% -1.30% +21.49% +13.79% -5.92% -12.18% n/a n/a n/a